Prithviraj Bose, MD

Articles

Unmet Needs in SM Treatment

September 27th 2021

The panel of experts in SM highlight the unmet needs in the clinical care of systemic mastocytosis.

Chronic Myelomonocytic Cell Leukemia: Clinical Considerations

September 27th 2021

The panel of experts discuss the diagnosis and assessment of chronic myelomonocytic cell leukemia.

Advanced Systemic Mastocytosis: Expert Insight into Epidemiology, Diagnosis, and Treatment

September 15th 2021

Learn more about the epidemiology, diagnosis, and treatment of advanced systemic mastocytosis in this summary from an expert multidisciplinary case-based discussion.

Dr. Bose on Risk Factors of Essential Thrombocythemia

December 3rd 2020

Prithviraj Bose, MD, discusses risk factors associated with essential thrombocythemia.

Dr. Bose on Current Treatment Options for Essential Thrombocythemia

October 15th 2020

Prithviraj Bose, MD, discusses current treatment options for essential thrombocythemia.

Dr. Bose on Novel Agents Under Investigation in Essential Thrombocythemia

September 17th 2020

Prithviraj Bose, MD, discusses novel agents under investigation in essential thrombocythemia.

Dr. Bose on the Management of Patients With Myelofibrosis Who Progress on Ruxolitinib

June 9th 2020

Prithviraj Bose, MD, discusses management strategies for patients with myelofibrosis who progress on ruxolitinib (Jakafi).

Dr. Bose on the Management of Patients With Myelofibrosis Who Progress on Ruxolitinib

June 8th 2020

Prithviraj Bose, MD, associate professor in the Department of Leukemia of the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center, discusses management strategies for patients with myelofibrosis who progress on ruxolitinib (Jakafi).

Dr. Bose on the Utility of Ruxolitinib in Myelofibrosis

June 6th 2020

Prithviraj Bose, MD, discusses the utility of ruxolitinib in patients with myelofibrosis.

Dr. Bose on Novel Agents Under Investigation in Myelofibrosis

May 14th 2020

Prithviraj Bose, MD, discusses novel agents under investigation in myelofibrosis.

Dr. Bose on Novel Agents Under Investigation in Myelofibrosis

May 14th 2020

Prithviraj Bose, MD, discusses novel agents under investigation in myelofibrosis.

Dr. Bose on Treating Progression in Patients With Myelofibrosis

February 14th 2020

Prithviraj Bose, MD, discusses treatment for patients with progressive myelofibrosis.